skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: Elsevier ScienceDirect Journals remover Nome da Publicação: European Journal Of Cancer Supplements remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment
Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment

Ribeiro, J ; Sousa, B ; Cardoso, F

European journal of cancer supplements, 2013-09, Vol.11 (2), p.3-22 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
5084 Pharmacokinetics and tolerability of lapatinib administered once daily in combination with tamoxifen
5084 Pharmacokinetics and tolerability of lapatinib administered once daily in combination with tamoxifen
Material Type:
Artigo 		Adicionar ao Meu Espaço

5084 Pharmacokinetics and tolerability of lapatinib administered once daily in combination with tamoxifen

Cardoso, F ; Koch, K.M ; Brain, E ; Lokiec, F ; Marreaud, S ; Bogaerts, J ; Fumoleau, P

European journal of cancer supplements, 2009, Vol.7 (2), p.286-286 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
444 The EORTC 10041/BIG 03–04 MINDACT trial is feasible: first results of the pilot phase
444 The EORTC 10041/BIG 03–04 MINDACT trial is feasible: first results of the pilot phase
Material Type:
Artigo 		Adicionar ao Meu Espaço

444 The EORTC 10041/BIG 03–04 MINDACT trial is feasible: first results of the pilot phase

Rutgers, E ; Piccart, M ; Delaloge, S ; Veer, L. Van't ; Rubio, I ; Viale, G ; Bogaerts, J ; Cardoso, F

European journal of cancer supplements, 2010, Vol.8 (3), p.188-188 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
213 Duplication of chromosome 17 CEP predicts for anthracycline benefit: evidence from an international meta-analysis of 4 adjuvant breast cancer trials for the HER2/TOP2A meta-analysis study group
213 Duplication of chromosome 17 CEP predicts for anthracycline benefit: evidence from an international meta-analysis of 4 adjuvant breast cancer trials for the HER2/TOP2A meta-analysis study group
Material Type:
Artigo 		Adicionar ao Meu Espaço

213 Duplication of chromosome 17 CEP predicts for anthracycline benefit: evidence from an international meta-analysis of 4 adjuvant breast cancer trials for the HER2/TOP2A meta-analysis study group

Bartlett, J.M.S ; Munro, A ; O'Malley, F.P ; Earl, H ; Poole, C.J ; Cardoso, F ; Twelves, C.J ; Pritchard, K.I ; Rea, D.W ; Di Leo, A

European journal of cancer supplements, 2010, Vol.8 (3), p.121-121 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab
5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab

Cardoso, F ; Gianni, L ; Jerusalem, G ; Fasolo, A ; Bergh, J ; Dieras, V ; Manlius, C ; Mukhopadhyay, P ; Massacesi, C ; Sahmoud, T

European journal of cancer supplements, 2009, Vol.7 (2), p.261-261 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer
5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer

Cardoso, F ; Canon, J.L ; Amadori, D ; Dirix, L ; Villa, E ; Aldrighetti, D ; Machiels, J.P ; Verkh, L ; Kern, K ; Giorgetti, C

European journal of cancer supplements, 2009, Vol.7 (2), p.283-283 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Progress in systemic therapy for breast cancer: an overview and perspectives
Progress in systemic therapy for breast cancer: an overview and perspectives
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progress in systemic therapy for breast cancer: an overview and perspectives

Piccart, M.J. ; Cardoso, F.

EJC Supplements, 2003-09, Vol.1 (2), p.56-69 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
The 70-gene profile is a powerful predictor of disease outcome in breast cancer patients with 1–3 positive lymph nodes
The 70-gene profile is a powerful predictor of disease outcome in breast cancer patients with 1–3 positive lymph nodes
Material Type:
Artigo 		Adicionar ao Meu Espaço

The 70-gene profile is a powerful predictor of disease outcome in breast cancer patients with 1–3 positive lymph nodes

Mook, S ; Schmidt, M.K ; Viale, G ; Pruneri, G ; Eekhout, I ; Piccart-Gebhart, M.J ; Cardoso, F ; Rutgers, E.J ; van't Veer, L.J

European journal of cancer supplements, 2008, Vol.6 (7), p.195-195 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group
Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group

Daidone, Maria Grazia ; Foekens, John A ; Harbeck, Nadia ; Martens, John ; Brunner, Nils ; Thomssen, Christoph ; Hall, Jacqueline A ; Salgado, Roberto ; Dittmer, Juergen ; Geurts-Moespot, Anneke ; Duffy, M. Joe ; Sweep, Fred C.G.J ; Schmitt, Manfred

European journal of cancer supplements, 2012-03, Vol.10 (1), p.120-127 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Progress in systemic therapy for breast cancer: an overview and perspectives: New approaches in cancer treatments
Progress in systemic therapy for breast cancer: an overview and perspectives: New approaches in cancer treatments
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progress in systemic therapy for breast cancer: an overview and perspectives: New approaches in cancer treatments

PICCART, M. J ; CARDOSO, F

European journal of cancer supplements, 2003, Vol.1 (2), p.56-69 [Periódico revisado por pares]

Oxford: Elsevier

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.